A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to Johnson & Johnson’s product.
Published: December 17, 2021 at 12:00AM
from NYT Health https://ift.tt/3DXe7NH
A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to Johnson & Johnson’s product.
Published: December 17, 2021 at 12:00AM
from NYT Health https://ift.tt/3DXe7NH